There is no step-count target in official US physical activity guidelines, and the 10,000 figure everyone quotes came from a product name, not a study. The best evidence in older women — a Harvard analysis of 16,741 women averaging 72 years old — found that those walking about 4,400 steps a day had roughly 41% lower all-cause mortality over 4.3 years than those walking about 2,700, with the curve flattening around 7,500 steps. A 2025 systematic review of 57 studies converged on about 7,000 steps a day as a sensible general goal. For most midlife women, 7,000–8,000 steps is a well-supported target — and if you are currently at 3,000, getting to 5,000 buys you more than getting from 8,000 to 10,000 ever will.
Where did 10,000 steps actually come from?
In 1965, in the wash of national fitness enthusiasm after the 1964 Tokyo Olympics, the Japanese company Yamasa Clock launched a pedometer called the manpo-kei — literally "10,000-step meter." The number was chosen because it was round, memorable, and because the Japanese character for 10,000 (万) resembles a walking figure. No trial had tested it. No committee had reviewed it. It was a good name for a product.
Sixty years later it is the default goal on nearly every wearable sold, which is how a marketing decision became something people feel guilty about missing. That is worth naming plainly, because the guilt is doing real harm: if 10,000 feels unreachable on a working day, the rational response is often to stop tracking altogether — and the evidence says the steps you would have taken at 5,000 or 6,000 were the ones that mattered most.
What do the studies in older women actually show?
The single most relevant study for this audience is I-Min Lee and colleagues' 2019 analysis in JAMA Internal Medicine, drawn from the Women's Health Study. It is directly on point: 16,741 women, mean age 72, wearing hip-worn accelerometers (research-grade, not consumer watches), followed a mean of 4.3 years, with 504 deaths recorded.
Median steps by quartile were 2,718, 4,363, 5,905 and 8,442 per day. Compared with the least active quartile, adjusted hazard ratios for death were 0.59, 0.54 and 0.42 — meaning the second quartile, at roughly 4,400 steps, already carried about 41% lower mortality risk. The dose–response curve declined steadily up to approximately 7,500 steps a day, then levelled.
Two broader analyses back this shape. Paluch and colleagues pooled 15 international cohorts (nearly 50,000 adults) in The Lancet Public Health in 2022 and found that in adults aged 60 and over, mortality risk plateaued at roughly 6,000–8,000 steps a day; in adults under 60 the plateau sat higher, around 8,000–10,000. In 2025, Ding and colleagues published a dose–response meta-analysis of 57 studies in the same journal, covering mortality, cardiovascular disease, cancer, type 2 diabetes, dementia, depressive symptoms, physical function and falls. Inflection points clustered around 5,000–7,000 steps, and 7,000 steps a day was associated with about 47% lower all-cause mortality and about 38% lower dementia risk compared with 2,000 steps. Above 7,000, additional gains for most outcomes were modest.
The honest caveats
All of this is observational. People who walk more are, on average, healthier to begin with, and illness reduces walking long before it shows up as a diagnosis — a problem called reverse causation. Good studies adjust for baseline health and exclude early deaths, and the associations survive, but no randomised trial has assigned people to 4,000 versus 8,000 steps and measured who lives longer. The direction of the evidence is consistent and biologically plausible. The exact numbers are not precise, and anyone presenting 7,000 as a hard threshold is overselling it.
What does each step band buy you?
| Daily steps | What the evidence shows | Practical read |
|---|---|---|
| Under 3,000 | The reference group in most cohorts — highest mortality, cardiovascular and dementia risk. Typical of a desk job with car commuting. | The single biggest opportunity. Any increase from here shows the steepest benefit in the data. |
| 4,000–5,000 | In the Women's Health Study, ~4,400 steps carried roughly 41% lower mortality than ~2,700. The 2025 meta-analysis found ~4,000 clearly better than ~2,000. | Already a meaningful health position. Not "failing at 10,000." |
| 6,000–7,000 | Where inflection points cluster across 57 studies for mortality, cardiovascular disease, dementia and falls. About 47% lower all-cause mortality vs 2,000 steps. | A realistic, evidence-anchored target for most midlife women. |
| 7,500–8,000 | Where the mortality curve levels off in older women (Lee 2019) and in adults 60+ (Paluch 2022). | Where the return on extra effort starts to flatten for longevity outcomes. |
| 10,000+ | Not harmful, and possibly better for some outcomes — one UK Biobank analysis put the "optimal" dementia dose near 9,800 steps. Gains beyond ~7,000 are generally modest. | A fine goal if you enjoy it. A poor reason to feel you have failed at 8,200. |
Does walking faster matter, or just the total?
This is genuinely contested, and the honest answer is: total volume is the stronger, better-replicated signal.
In the Lee study, once total daily steps were accounted for, measures of stepping intensity — including peak 30-minute cadence — largely lost significance (HR 0.87, 95% CI 0.68–1.11). The authors concluded that in older women, step volume rather than intensity appeared more important. Other work points the other way: UK Biobank analyses have linked a higher peak 30-minute cadence (around 112 steps per minute) to lower dementia risk independent of volume.
A workable reconciliation: get the steps first, then add a brisk portion if you can. Roughly 100 steps per minute is the widely used research threshold for moderate intensity in adults — the pace at which conversation gets slightly clipped. Even 10 or 15 minutes of your daily walk at that cadence pushes you into the moderate-intensity minutes that guidelines are built around. If your knees or hips object to speed, extra minutes at your own pace are a legitimate substitute — the volume evidence is on your side.
Why steps alone are not enough after 45
Walking is excellent for cardiovascular risk, glucose handling, mood and mortality. It is comparatively weak for two things that matter enormously in midlife: muscle mass and bone density.
Oestrogen decline through perimenopause accelerates bone loss and works against muscle maintenance, and steady-state walking supplies neither the mechanical loading that stimulates bone nor the progressive overload that builds muscle. US physical activity guidelines reflect this — they ask for 150 minutes a week of moderate activity plus muscle-strengthening on two or more days. The second half is the part most people skip. Two short sessions a week of resistance training is the evidence-supported complement to a walking habit, and it is directly relevant to bone loss around menopause. If longevity is the goal, steps plus strength beats steps alone. For a broader picture of what to prioritise in this decade, see our guide to exercise for menopause.
How accurate is your step counter?
Accurate enough to track your own trend; not accurate enough to compare against a study threshold.
Validation research is consistent on one point: wrist-worn trackers undercount at slow walking speeds. In a PLOS ONE study of six devices in older adults, mean absolute percentage error was small at normal walking pace but rose sharply as speed dropped — in the region of 20% or more at slow paces, and worse again when participants used a walking aid, because the wrist is not swinging normally. Hip-, thigh- and ankle-worn devices are considerably more accurate; the cohort studies quoted above mostly used hip-worn research accelerometers, which is one reason your watch's number and a study's number are not the same currency.
Two practical consequences. First, if you walk slowly or use a stick or frame, your watch is probably underselling you — treat its number as a floor. Second, compare your Tuesday to your own Monday, not to a headline. Consistency of device and placement matters more than the brand.
How to add 2,000 steps without reorganising your life
Two thousand steps is roughly 15–20 minutes of walking. That is the increment that moves most people from a low-benefit band into a well-supported one, and it does not require a gym membership.
- Anchor it to something you already do. A 10-minute walk after your largest meal picks up steps and blunts the post-meal glucose rise.
- Park or alight deliberately further out. One stop earlier on a bus route is often 800–1,200 steps, twice a day.
- Take calls standing and moving. A 20-minute phone call walked rather than sat is frequently 1,500–2,000 steps.
- Set the goal at your current average plus 1,000, not at 10,000. Baseline-plus is the version people keep doing in month three.
If weight is your primary motivation, be aware that walking's effect on the scale is modest on its own — we cover what it realistically does in walking for weight loss. If you want a sense of where your cardiovascular risk currently sits before setting goals, our heart risk check walks through the standard factors, and you can browse more in fitness.
When to see a doctor
Walking is safe for the overwhelming majority of people, and you do not need medical clearance to walk more. But some symptoms mean stopping and getting assessed rather than pushing through.
Seek emergency care (call 911 in the US) if you have chest pressure, tightness or pain during exertion; pain radiating to the jaw, neck, back or either arm; sudden severe breathlessness; fainting or near-fainting; or sudden one-sided weakness, facial droop or slurred speech. Women's heart attack symptoms more often present as unusual fatigue, nausea, sweating or back and jaw discomfort rather than classic crushing chest pain — exertional symptoms of this kind are not something to walk off.
Book a non-urgent appointment if your walking distance has dropped noticeably over weeks or months; you get calf pain that reliably starts after a set distance and stops with rest (a possible sign of peripheral arterial disease); you have new or worsening breathlessness on flat ground; you feel unusually exhausted by activity that used to be easy (worth checking thyroid function and iron status, both common in midlife women); you have had a fall or feel unsteady; or you have new joint pain or swelling that walking makes worse. Anyone with known cardiac disease, uncontrolled blood pressure, recent surgery, or symptoms during exertion should agree an activity plan with their clinician rather than self-prescribing intensity.
The bottom line
Ten thousand was a pedometer's name. The number the research keeps landing on is closer to 7,000, benefits are already substantial by 4,000–5,000, and the curve flattens somewhere around 7,500 for older women. Pair the walking with two strength sessions a week, add a brisk stretch if your joints allow it, and treat your tracker as a trend line rather than a verdict. The most valuable step you take this year is the one that moves your average up from wherever it currently sits.
